Search

everythinglearnresearchcommunity

for

Search:↓

Women with type 1 diabetes often have polycystic ovary syndrome and excess male hormones, which are frequently undiagnosed.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Dietary changes, including weight loss and a balanced diet, are important for managing PCOS, especially in overweight women.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

Teens with PCOS and a mom with PCOS have higher insulin resistance and lower adiponectin levels, which could signal early metabolic problems.

People with hair loss may have different levels of certain hormones due to changes in hormone processing.

More adolescent girls in urban areas of India have Polycystic Ovary Syndrome compared to those in rural areas.

Women with hyperandrogenic amenorrhea have similar bone density to healthy women but lower than androgenized women without amenorrhea, and high DHEAS levels might affect bone density.

The conclusion suggests that PCOS may persist due to genetic traits that, while harmful for female fertility, could have provided survival and reproductive benefits to males.

Minoxidil and finasteride can help with hair loss, but more research is needed to improve treatments for certain types of hair loss.

The document concludes that careful evaluation is needed to diagnose PCOS correctly due to similar symptoms in other conditions, and accurate testosterone level measurement is crucial.

Some patients with high prolactin levels don't show symptoms because they have a form of the hormone that's less active.

AMH is a good marker for diagnosing PCOS, but global standards are needed.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

Metformin effectively improves metabolic symptoms in women with PCOS, while alfacalcidiol does not have a significant impact.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

AMH levels can't reliably tell the difference between LOCAH and all types of PCOS in women with excessive hair growth.

Antiandrogens can treat female hormonal conditions, but environmental ones may harm reproductive health.

Androgens affect many aspects of female health, and more research is needed to understand their roles and treatment potential.

Effective PCOS treatments require targeting specific signaling pathways.

Higher testosterone levels in Nigerian women with PCOS are linked to glucose disorders like diabetes.

The document concludes that accurate diagnosis of male and female gonadal disorders is crucial for effective treatment and better patient outcomes.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

There is no significant link between insulin resistance and certain hair disorders like idiopathic hirsutism and androgenic alopecia.

Hair loss is a common but often unreported side effect of cancer treatments, especially for breast and prostate cancers.

Hair loss is a common side effect of hormone treatments for cancer.

Hyperthyroidism can hide signs of high androgen levels in females.

Hysteroscopic surgery is better than hysterectomy for treating dysfunctional uterine bleeding due to fewer complications and quicker recovery, with high satisfaction in both treatments.